Tag Archives: Abbott
UnitedHealth Group Inc.’s (NYSE:UNH) Turns Red in Q4, Courtesy to High Costs – UNH, PM, MDT, PFE, ARNA, ABT, HLF, DNDN, AVEO
UnitedHealth Group Inc.’s (NYSE:UNH) declared that its fourth-quarter earnings plunged 1.1% among superior medical costs, thoughhiked membership assisted to enhance revenue.
UnitedHealth (UNH), the largest managed-care firm in terms of revenue, is the industry’s first to announce quarterly results, making …
ArQule Inc. (NASDAQ:ARQL) and Daiichi Sankyo Co. reported a study indicated the joint use of tivantinib with two other cancer-fighting cures did not meet the survival targets for patients with wayward or reverted colorectal cancer.
The pharmaceutical companies reported tivantinib, …
Biogen Idec Inc. (NASDAQ:BIIB) Stops Developing dexpramipexole after Trial Failure – BIIB, PFE, CELG, ABT, BGMD, AEZS, MRK, UNH, BSX
Biogen Idec Inc. (NASDAQ:BIIB) reported that its Phase 3 clinical trial for an ALS therapy did not match its keyobjectives, causing the biopharmaceutical company to end development of the medicine for the disease.
Shares of the company plunged 5.9% to …
Salix Pharmaceuticals Ltd.’s (NASDAQ:SLXP) Gets FDA Approval for Fulyzaq – SLXP, GSK, WCRX, PFE, MRK, HLF, ABT, VVUS, WPI
The Food and Drug Administration has accepted the initial anti-diarrheal drug for HIV/AIDS patients, Salix Pharmaceuticals Ltd.’s (NASDAQ:SLXP) Fulyzaq.
The medicine, also called as crofelemer, is created to get rid of symptoms of noninfectious diarrhea in patients with HIV/AIDS on …
Abbott Laboratories (ABT) Gets FDA’s Green Signal for Humira – ABT, MRK, SNY, DNDN, BSX, WCRX, PFE, BMY, PPHM
Abbott Laboratories Inc. (NYSE:ABT) reported on Friday that the Food and Drug Administration accepted its drug Humira as a cure for ulcerative colitis in adults.
The FDA accepted Humira as a cure for modest to harsh ulcerative colitis when other …
Healthcare Sector Ends in Positive Territory; Medivation (NASDAQ:MDVN) Wins U.S. Approval for New Drug Xtandi – MDVN, SCMP, ABT, CUR, IDRA
Healthcare sector responded positively on Friday’s trading session and sector climbed +0.30%. If we look at the top movers of the sector so Neuralstem, Inc (NYSEAMEX:CUR) and Idera Pharmaceuticals Inc (NASDAQ:IDRA) was major percentage gainer while major percentage Losers was …
